The Queen Mary Hospital, located in Pok Fu Lam on Hong Kong Island of Hong Kong, is the public district general hospital and teaching hospital of the Faculty of Dentistry and Li Ka Shing Faculty of Medicine of the University of Hong Kong. It has 1,706 beds.

There are 1,711 beds in Queen Mary Hospital; Department of Ophthalmology.

During the past decade, Queen Mary Hospital; Department of Ophthalmology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Mary Hospital; Department of Ophthalmology" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Queen Mary Hospital; Department of Ophthalmology" are "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Queen Mary Hospital; Department of Ophthalmology" in a lesser frequency.

Most popular intervention types in "Queen Mary Hospital; Department of Ophthalmology" are "Drug" (7 trials), "Procedure" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (5 trials), "Port Delivery System with ranibizumab (PDS)" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Mary Hospital; Department of Ophthalmology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Queen Mary Hospital; Department of Ophthalmology". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Queen Mary Hospital; Department of Ophthalmology, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Mary Hospital; Department of Ophthalmology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".